Fibrin Glue Market - Global Industry Analysis, Size and Forecast, 2023





Market Synopsis of Fibrin Glue

According to the study, the global fibrin glue market is likely to grow significantly during the forecast period, mainly due to increasing number of surgical procedures and burn cases, and rising healthcare expenditure. According to the data provided by the World Bank, 30,537 surgeries were performed per 100,000 population, in 2012, in the U.S. Similarly, in 2015, number of surgical procedures performed in Australia were 28,907 per 100,000 population. Fibrin glue is used in various types of surgeries. Fibrin glue is also used in burn cases during plastic surgeries and surgery of the burned body parts. According to WHO, approximately 265,000 deaths every year are caused by burns.

Read Fibrin Glue sample report here : http://bit.ly/2FssiNf

Geographically, North America has been the largest market for fibrin glue, with the U.S. being the larger contributor to the regional market, compared to Canada. High prevalence of cardiovascular diseases is a key factor driving the growth of North America fibrin glue market for cardiac surgery.
Regional Analysis of Hospital Infection Therapeutics Market.

Additionally, the growth of the fibrin glue market in this region is driven by the rise in number of surgical procedures; especially plastic surgeries in the region, high expenditure on healthcare, increasing geriatric population, high number of road accidents and burn cases. According to American Heart Association (AHA), around 85.6 million people are living with cardiovascular diseases, in the U.S. According to Centers for Disease Control and Prevention (CDC), total national healthcare expenditure in the U.S. was $3.0 trillion in 2014 and per capita national health expenditure was $9,523.

Request sample report here : http://bit.ly/2tnXL1o

Fibrin glues are usually used for wound closure, bronchial fistulas, repairing dura tears and haemostasis for liver and spleen trauma. Many companies are investing in research and development for expanding the indications for which fibrin glue can be used in addition to their existing indications.

Key Players

Some of the key players operating in the global fibrin glue market include Vivostat A/S, Kaketsuken, Johnson & Johnson, Baxter International Inc., CSL Behring, Zimmer Biomet Holdings, Inc., Takeda Pharmaceutical Company Limited, Mallinckrodt Plc, Shanghai RAAS Blood Products Co. Ltd. and Hualan Biological Engineering Inc.



Contact:

P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com



Comments

Post a Comment

Popular posts from this blog

Clinical Decision Support System (CDSS) Market Segment Forecasts - 2022

Image
Market Synopsis of Clinical Decision Support System : The global CDSS Market was valued at $410.5 million in 2015, and it is expected to grow at a CAGR of 21.5% during 2016-2022. Among the various products, the integrated Clinical Decision Support System segment is expected to witness the fastest growth, CAGR of 22.4%, during the forecast period. The global CDSS market is growing at a significant rate, due to growing demand for advanced healthcare information systems, and growing investments by HIT players. In addition, the growing need for remote patient monitoring services and increasing support from government organizations is also driving the growth of the global CDSS market. Read market summary report here : http://bit.ly/2tF1nMJ Regional Analysis of Clinical Decision Support System Market Geographically, North America dominated the global market of CDSS in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth at a CAGR of 23.2%, during the fo...
Read more